A Study to Assess the Abuse Potential of Intranasal Cebranopadol (clinicaltrials.gov) - Sep 5, 2025 - P1 | N=48 | Completed | Sponsor: Tris Pharma, Inc. | Active, not recruiting ➔ Completed | Trial completion date: Mar 2025 ➔ Nov 2024
Trial completion • Trial completion date • Addiction (Opioid and Alcohol)
|